PAR paradigm biopharmaceuticals limited..

Ann: Paradigm to Present at Evercore ISI HealthCONx Conference, page-142

  1. 41 Posts.
    lightbulb Created with Sketch. 10
    yeah, agreed. These stocks are typically too hard to time and jump in and out of. You’ll miss the big pops. Over time you add if you want when the chart tells you to, but most of the time it just sits and it’s best to keep it out of mind. If this stock hits its a 10-50 bagger. If not you lose the 3-5% of your overall portfolio. That’s what we like to call asymmetrical risk/reward. However, you cannot have an oversized portion of your portfolio allocated to it. It’s the candy if you will.

    For everyone crying that it’s two years - it’s really not. Q3 2022 could be September 2022 and 2024 could be early in the year. Relax. R-E-L-A-X. Relax.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
-0.020(4.55%)
Mkt cap ! $168.9M
Open High Low Value Volume
44.5¢ 44.5¢ 41.5¢ $271.6K 637.8K

Buyers (Bids)

No. Vol. Price($)
2 5960 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 3696 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.